Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004.
about
Uncertain outcomes: adjusting for misclassification in antimalarial efficacy studiesAssessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: the role of Médecins Sans FrontièresRevisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.Resistance to therapies for infection by Plasmodium vivaxWorld Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial.Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria.Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children.The effect of varying analytical methods on estimates of anti-malarial clinical efficacy.The rationale and plan for creating a World Antimalarial Resistance Network (WARN).Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trialsGenotyping of Plasmodium falciparum using antigenic polymorphic markers and to study anti-malarial drug resistance markers in malaria endemic areas of Bangladesh.Statistical methods to derive efficacy estimates of anti-malarials for uncomplicated Plasmodium falciparum malaria: pitfalls and challenges.Analysing malaria drug trials on a per-individual or per-clone basis: a comparison of methods.
P2860
Q28391984-9DE9036F-2DD7-49A4-AD18-08F2A99B6914Q33358271-BB4657F2-4026-4BE5-862A-727565C6130BQ33385477-2DDA73D5-31A9-4287-A939-15D6C7F00E6CQ33481576-FA27E5D8-2B47-45E8-A7B4-7051BEB65DF3Q36037701-05C447E7-02E7-48F3-ADA9-E609A43C0C00Q36146216-E1E8443C-824C-4A75-891B-4F07D4C68857Q36691877-30D3BD97-2086-480B-BA9F-E38D75D75074Q36782415-47E812B9-5EB2-4706-B113-C8FADB1C8011Q36855449-2B491B36-7744-4CFA-ACD2-275E0A2E4D33Q37184291-3821BC3F-8922-4E25-AF2F-E1E937EFB635Q41540119-921C5621-DEF4-4A58-819C-69F27558AFB9Q41868814-26E1D70E-C959-4C5C-8169-531B0069FCCAQ41927676-7C80B00E-BFD6-43CC-93A8-BE9E11E240ACQ42617661-8CCB45C0-F8DD-45D4-9A36-B6FDB2B70422Q46865781-0AAF244A-517E-4BFA-BA39-515296F5F899
P2860
Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Methodological issues in the a ...... n countries from 2001 to 2004.
@ast
Methodological issues in the a ...... n countries from 2001 to 2004.
@en
type
label
Methodological issues in the a ...... n countries from 2001 to 2004.
@ast
Methodological issues in the a ...... n countries from 2001 to 2004.
@en
prefLabel
Methodological issues in the a ...... n countries from 2001 to 2004.
@ast
Methodological issues in the a ...... n countries from 2001 to 2004.
@en
P2093
P2860
P356
P1476
Methodological issues in the a ...... n countries from 2001 to 2004.
@en
P2093
Dominique Legros
Francesco Checchi
Jean-Paul Guthmann
Loretxu Pinoges
Michel van Herp
Suna Balkan
P2860
P304
P356
10.1128/AAC.01618-05
P407
P577
2006-09-05T00:00:00Z